Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)

Tundra lists 1 Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT05063162

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

The purpose of the study is to evalute the efficacy, safety and tolerability of rozanolixizumab for treatment of adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD).

Gender: All

Ages: 18 Years - 89 Years

Updated: 2026-03-13

13 states

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)